These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30884769)

  • 1. Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue.
    Gowkielewicz M; Lipka A; Piotrowska A; Szadurska-Noga M; Nowakowski JJ; Dzięgiel P; Majewski MK; Jozwik M; Majewska M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue.
    Gowkielewicz M; Lipka A; Majewska M; Piotrowska A; Szadurska-Noga M; Nowakowski JJ; Wiszpolska M; Dzięgiel P; Wasniewski T; Majewski MK; Jozwik M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer.
    Dogan NU; Kerimoglu OS; Karabagli P; Pekin A; Yilmaz SA; Incesu F; Celik C
    J Obstet Gynaecol; 2015 Feb; 35(2):178-82. PubMed ID: 25111828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear Cell Lesions of the Mullerian System: Not Always That "Clear"!
    Wawire J; Lawrence WD; Quddus MR
    Int J Surg Pathol; 2019 Dec; 27(8):884-886. PubMed ID: 30917732
    [No Abstract]   [Full Text] [Related]  

  • 6. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.
    Fortner RT; Schock H; Jung S; Allen NE; Arslan AA; Brinton LA; Egleston BL; Falk RT; Gunter MJ; Helzlsouer KJ; Idahl A; Johnson TS; Kaaks R; Krogh V; Lundin E; Merritt MA; Navarro C; Onland-Moret NC; Palli D; Shu XO; Sluss PM; Staats PN; Trichopoulou A; Weiderpass E; Zeleniuch-Jacquotte A; Zheng W; Dorgan JF
    Br J Cancer; 2017 Oct; 117(9):1412-1418. PubMed ID: 28873086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Mullerian hormone as a parameter for endometrial trauma in Asherman syndrome: A retrospective data analysis.
    Promberger R; Ott J
    Reprod Biol; 2017 Jun; 17(2):151-153. PubMed ID: 28400095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
    Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.
    Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
    Georgian Med News; 2018 Mar; (276):117-123. PubMed ID: 29697394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria.
    Kim SM; Kim YO; Lee MK; Chung YJ; Jeung IC; Kim MR; Kim JH
    Oncol Lett; 2019 Jan; 17(1):532-538. PubMed ID: 30655798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial cancer, turned out to be an endometroid ovarian cancer stage II].
    Lazarov N; Lazarov L; Laarov S; Velev V; Ananiev J
    Akush Ginekol (Sofiia); 2011; 50(6):48-50. PubMed ID: 22452068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 in imprint smears of endometrial carcinoma.
    Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
    Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
    Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells.
    Signorile PG; Petraglia F; Baldi A
    J Exp Clin Cancer Res; 2014 May; 33(1):46. PubMed ID: 24886254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.